Company intelligence / Profile preview

MindTrace

Pittsburgh, Pennsylvania, United Statesmindtrace.com ↗

Ownership: Private
Employees: ~15
Development stage: Other

Overview

MindTrace is a medical technology company that develops AI-driven software designed to protect a patient's cognitive integrity during neurosurgery. The company's platform integrates neuropsychological testing with neuroimaging to provide surgeons with a "mind-map" that predicts functional outcomes before the first incision is made. By simulating surgical resections, MindTrace helps clinicians avoid critical brain regions responsible for speech, memory, and movement. The technology aims to reduce post-operative cognitive deficits in patients undergoing surgery for brain tumors or epilepsy.

Therapeutic areas: OncologyNeurology
Modalities: DeviceNon-pharmacological therapy
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on MindTrace.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MindTrace.

Explore the full profile